177 related articles for article (PubMed ID: 33207819)
21. Extraosseous primary and recurrent giant cell tumors: transforming growth factor-beta1 and -beta2 expression may explain metaplastic bone formation.
Teot LA; O'Keefe RJ; Rosier RN; O'Connell JX; Fox EJ; Hicks DG
Hum Pathol; 1996 Jul; 27(7):625-32. PubMed ID: 8698303
[TBL] [Abstract][Full Text] [Related]
22. Interleukin-1beta upregulates MMP-9 expression in stromal cells of human giant cell tumor of bone.
Rao VH; Singh RK; Delimont DC; Schaefer GB; Bridge JA; Neff JR; Sanger WG; Sappenfield JW; Buehler BA; Finnell RH
J Interferon Cytokine Res; 1999 Oct; 19(10):1207-17. PubMed ID: 10547161
[TBL] [Abstract][Full Text] [Related]
23. Quantitative proteomic analysis of dermal papilla from male androgenetic alopecia comparing before and after treatment with low-level laser therapy.
Panchaprateep R; Pisitkun T; Kalpongnukul N
Lasers Surg Med; 2019 Sep; 51(7):600-608. PubMed ID: 30843235
[TBL] [Abstract][Full Text] [Related]
24. Analyzing BMP2, FGFR, and TGF Beta Expressions in High-Grade Osteosarcoma Untreated and Treated Autografts Using Proteomic Analysis.
Madda R; Chen CM; Chen CF; Wang JY; Wu HY; Wu PK; Chen WM
Int J Mol Sci; 2022 Jul; 23(13):. PubMed ID: 35806417
[TBL] [Abstract][Full Text] [Related]
25. [GIANT CELL TUMOR OF BONE: RESULTS AND TREATMENT COMPLICATIONS].
Bergovec M; Petković M; Smerdelj M; Seiwerth S; Brkić L; Robert K; Orlić D
Acta Med Croatica; 2014 Dec; 68(4-5):405-10. PubMed ID: 26285474
[TBL] [Abstract][Full Text] [Related]
26. Characterization of MicroRNA Expression Profiles in Patients with Giant Cell Tumor.
Qin S; He NB; Yan HL; Dong Y
Orthop Surg; 2016 May; 8(2):212-9. PubMed ID: 27384730
[TBL] [Abstract][Full Text] [Related]
27. Conservative surgery for giant cell tumors of the sacrum. The role of cryosurgery as a supplement to curettage and partial excision.
Marcove RC; Sheth DS; Brien EW; Huvos AG; Healey JH
Cancer; 1994 Aug; 74(4):1253-60. PubMed ID: 8055446
[TBL] [Abstract][Full Text] [Related]
28. Giant-cell tumors of the carpus.
Shigematsu K; Kobata Y; Yajima H; Kawamura K; Maegawa N; Takakura Y
J Hand Surg Am; 2006 Sep; 31(7):1214-9. PubMed ID: 16945730
[TBL] [Abstract][Full Text] [Related]
29. Giant cell tumor of the cervical spine treated by carbon ion radiotherapy: A case report.
Sakuda T; Furuta T; Okimoto T; Adachi N
Medicine (Baltimore); 2021 Oct; 100(41):e27393. PubMed ID: 34731109
[TBL] [Abstract][Full Text] [Related]
30. [Factors related to biologic behavior in giant cell tumor of bone].
Ran XY; Huang J; Zhang HZ; Jiang ZM; Chen J
Zhonghua Bing Li Xue Za Zhi; 2013 Oct; 42(10):669-74. PubMed ID: 24433729
[TBL] [Abstract][Full Text] [Related]
31. Regulation of MMP-9 (92 kDa type IV collagenase/gelatinase B) expression in stromal cells of human giant cell tumor of bone.
Rao VH; Singh RK; Bridge JA; Neff JR; Schaefer GB; Delimont DC; Dunn CM; Sanger WG; Buehler BA; Sawaya R; Nicolson GL; Rao JS
Clin Exp Metastasis; 1997 Jul; 15(4):400-9. PubMed ID: 9219728
[TBL] [Abstract][Full Text] [Related]
32. Percutaneous CT-Guided Cryoablation as an Alternative Treatment for an Extensive Pelvic Bone Giant Cell Tumor.
Panizza PS; de Albuquerque Cavalcanti CF; Yamaguchi NH; Leite CC; Cerri GG; de Menezes MR
Cardiovasc Intervent Radiol; 2016 Feb; 39(2):299-303. PubMed ID: 26126580
[TBL] [Abstract][Full Text] [Related]
33. [Survivin and COX-2 expressions in giant cell tumor of bone and their relation to the prognosis].
Luo SM; Liu RD; Li WR; Hou JH
Nan Fang Yi Ke Da Xue Xue Bao; 2009 Jan; 29(1):156-9. PubMed ID: 19218139
[TBL] [Abstract][Full Text] [Related]
34. Gene expression of transforming growth factor-beta 1 and its type II receptor in giant cell tumors of bone. Possible involvement in osteoclast-like cell migration.
Zheng MH; Fan Y; Wysocki SJ; Lau AT; Robertson T; Beilharz M; Wood DJ; Papadimitriou JM
Am J Pathol; 1994 Nov; 145(5):1095-104. PubMed ID: 7977641
[TBL] [Abstract][Full Text] [Related]
35. Expression of preosteoblast markers and Cbfa-1 and Osterix gene transcripts in stromal tumour cells of giant cell tumour of bone.
Huang L; Teng XY; Cheng YY; Lee KM; Kumta SM
Bone; 2004 Mar; 34(3):393-401. PubMed ID: 15003787
[TBL] [Abstract][Full Text] [Related]
36. [Giant cell tumor of bone. An evaluation of 87 patients].
Tunn PU; Schlag PM
Z Orthop Ihre Grenzgeb; 2003; 141(6):690-8. PubMed ID: 14679436
[TBL] [Abstract][Full Text] [Related]
37. STAT1, IGF1, RAC1, and MDM2 Are Associated with Recurrence of Giant Cell Tumor of Bone.
Chen S; Du Z; Wu B; Shen H; Liu C; Qiu X; Zhang Y; Xu L; Li E; Zhong Z
J Immunol Res; 2018; 2018():4564328. PubMed ID: 29651441
[TBL] [Abstract][Full Text] [Related]
38. Gene expression of osteoprotegerin ligand, osteoprotegerin, and receptor activator of NF-kappaB in giant cell tumor of bone: possible involvement in tumor cell-induced osteoclast-like cell formation.
Huang L; Xu J; Wood DJ; Zheng MH
Am J Pathol; 2000 Mar; 156(3):761-7. PubMed ID: 10702390
[TBL] [Abstract][Full Text] [Related]
39. TGF-beta isoform and receptor expression in giant cell tumor and giant cell lesions of bone.
Franchi A; Benvenuti S; Masi L; Malentacchi C; Arganini L; Brandi ML; Santucci M
Appl Immunohistochem Mol Morphol; 2001 Jun; 9(2):170-5. PubMed ID: 11396635
[TBL] [Abstract][Full Text] [Related]
40. Label-Free LC-MS/MS Proteomic Analysis of Cerebrospinal Fluid Identifies Protein/Pathway Alterations and Candidate Biomarkers for Amyotrophic Lateral Sclerosis.
Collins MA; An J; Hood BL; Conrads TP; Bowser RP
J Proteome Res; 2015 Nov; 14(11):4486-501. PubMed ID: 26401960
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
